2025-02-01 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Report

**0) Executive Summary:**

Intuitive Surgical Inc. (ISRG) is a leading developer and manufacturer of robotic surgery systems.  This report analyzes ISRG's performance against the S&P 500 (VOO), considering its recent price movements, financial indicators, and earnings.  The analysis reveals significant outperformance relative to the benchmark, however, recent price action suggests potential short-term volatility.

**1) Performance Comparison:**

Intuitive Surgical Inc. (ISRG) develops and manufactures the da Vinci surgical system, a robotic surgical system used in minimally invasive procedures.

* **Cumulative Return (ISRG):** 317.08%
* **Cumulative Return (VOO):** 119.91%
* **Return Difference:** 197.17%
* **Relative Outperformance:** 88.6% (based on historical range of the difference).

ISRG has significantly outperformed the S&P 500 over the measured period.  The high relative outperformance suggests substantial historical outperformance compared to its own past.  However, it is crucial to remember that past performance is not indicative of future results.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 77.0% | 7.3% | 49.0% | -0.0 | 43.3 |
| 2016-2018  | 89.0% | 8.9% | 71.0% | 0.0 | 56.9 |
| 2017-2019  | 93.0% | 9.8% | 63.0% | 0.5 | 70.2 |
| 2018-2020  | 71.0% | 9.8% | 43.0% | 0.2 | 97.1 |
| 2019-2021  | 113.0% | 9.8% | 42.0% | 0.2 | 128.0 |
| 2020-2022  | 21.0% | 20.6% | 12.0% | 0.2 | 94.5 |
| 2021-2023  | 19.0% | 20.6% | -4.0% | 1.0 | 120.2 |
| 2022-2024  | 128.0% | 20.4% | 95.0% | 1.0 | 185.9 |
| 2023-2025  | 211.0% | 9.9% | 150.0% | 0.8 | 203.7 |

The table shows consistently high CAGR (Compound Annual Growth Rate) for ISRG, exceeding the market significantly (implied by high alpha values).  The relatively low MDD (Maximum Drawdown) indicates resilience during market corrections.  Beta values show varying sensitivity to overall market movements; however, many periods show less market sensitivity (Beta<1).


**2) Recent Price Movement:**

* **Closing Price:** $571.88
* **Previous Close:** $580.18
* **Change:** -$1.43 (-0.25%)
* **5-Day Moving Average:** $574.48
* **20-Day Moving Average:** $567.01
* **60-Day Moving Average:** $546.17

The price is slightly below its 5-day moving average, suggesting a short-term downward trend.  However, it remains above both the 20-day and 60-day moving averages, indicating a potentially longer-term upward trend. The recent drop is relatively small and might not represent a significant change in trend.


**3) Technical Indicators and Expected Return:**

* **RSI:** 59.04 (Slightly above neutral; not overbought)
* **PPO:** -0.26 (Slightly negative; indicating bearish momentum)
* **20-Day Relative Divergence Change:** -2.8% (Short-term downward trend)
* **Expected Return (2+ years):** 22.4% (above S&P 500)

The RSI suggests the stock is not overbought, while the negative PPO indicates bearish momentum.  The recent price drop might be a short-term correction.  The substantial positive expected return relative to the S&P 500 supports the long-term investment thesis.


**4) Recent Earnings Analysis:**

| Date       | EPS     | Revenue      |
|------------|---------|--------------|
| 2024-10-18 | $1.59   | $2.04B       |
| 2024-07-19 | $1.48   | $2.01B       |
| 2024-04-19 | $1.54   | $1.89B       |
| 2023-10-20 | $1.18   | $1.74B       |
| 2024-10-18 | $1.18   | $1.74B       | *(Duplicate Entry - Likely an error in data)*


Revenue shows a generally upward trend, with some minor fluctuations. EPS also demonstrates growth, except for a possible decline in Q4 2023.  The duplicate entry needs clarification.


**5) Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-09-30 | $2.04B | 67.41% |
| 2024-06-30 | $2.01B | 68.30% |
| 2024-03-31 | $1.89B | 65.87% |
| 2023-12-31 | $1.93B | 66.24% |
| 2023-09-30 | $1.74B | 66.94% |

Revenue shows growth and relatively stable and high profit margins.


**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-09-30 | $15.58B | 3.63% |
| 2024-06-30 | $14.71B | 3.58% |
| 2024-03-31 | $13.96B | 3.90% |
| 2023-12-31 | $13.31B | 4.56% |
| 2023-09-30 | $12.54B | 3.32% |

Equity is growing steadily, indicating strong financial health. ROE (Return on Equity) fluctuates but generally remains positive, though showing some recent decline.


**6) Overall Analysis:**

ISRG demonstrates strong historical performance significantly outpacing the S&P 500.  Financial statements reveal robust revenue growth and high profit margins.  While recent price action shows a slight dip and some bearish momentum signals, the long-term outlook remains positive given the high expected return.  However, it's vital to monitor the recent earnings data for accuracy and potential risks.  The relatively high valuation (implied by high Beta and outperformance) should also be considered before investment decisions.  Further research into competitive landscape, technological advancements, and potential regulatory hurdles is crucial for a complete assessment.
